Antibiotic consumption in children prior to diagnosis of asthma

Fawziah Marra1, Carlo A Marra, Kathryn Richardson

  • 1University of British Columbia, BC, Canada. fawziah.marra@bccdc.ca

Insights

Children with asthma consume more antibiotics than those without. This pattern suggests diagnostic challenges and potential over-treatment in pediatric asthma cases.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology
  • Epidemiology

Background:

  • Diagnosing asthma in children is challenging, often leading to misdiagnosis of infections.
  • Limited data exists on antibiotic use patterns in children with asthma compared to healthy peers.

Purpose of the Study:

  • To investigate the magnitude and patterns of antibiotic consumption in children diagnosed with asthma.
  • To compare antibiotic use in asthmatic children versus non-asthmatic children.

Main Methods:

  • Utilized population-based data from 128,872 children with a minimum of 6 years of follow-up.
  • Calculated the adjusted rate-ratio (RR) of antibiotic dispensing for asthmatic versus non-asthmatic children.

Main Results:

  • Asthmatic children showed a higher rate-ratio (RR) of antibiotic consumption, ranging from 1.66 to 2.32 at age six.
  • Over half (52%) of children with asthma received antibiotics in the 6 months preceding their diagnosis.
  • Antibiotic use was higher in the month before asthma diagnosis (RR=1.66) and more prevalent in females.

Conclusions:

  • Children with asthma exhibit significantly higher antibiotic consumption compared to their non-asthmatic counterparts.
  • The observed antibiotic use patterns indicate difficulties in adhering to diagnostic guidelines for pediatric asthma, potentially resulting in misdiagnosis and overtreatment.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...